BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38608982)

  • 21. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
    Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
    Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
    Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
    Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery.
    Fang XB; Zhang JM; Xie X; Liu D; He CW; Wan JB; Chen MW
    Int J Pharm; 2016 Apr; 502(1-2):28-37. PubMed ID: 26784981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility and drug release behavior of curcumin conjugated gold nanoparticles from aminosilane-functionalized electrospun poly(N-vinyl-2-pyrrolidone) fibers.
    Kurniawan A; Gunawan F; Nugraha AT; Ismadji S; Wang MJ
    Int J Pharm; 2017 Jan; 516(1-2):158-169. PubMed ID: 27989821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
    Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
    Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
    Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
    Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.
    Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
    Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
    Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
    Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facile preparation of pH-sensitive chitosan microspheres for delivery of curcumin; characterization, drug release kinetics and evaluation of anticancer activity.
    Pooresmaeil M; Namazi H
    Int J Biol Macromol; 2020 Nov; 162():501-511. PubMed ID: 32574741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
    Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.
    Mahmoudi R; Ashraf Mirahmadi-Babaheidri S; Delaviz H; Fouani MH; Alipour M; Jafari Barmak M; Christiansen G; Bardania H
    J Biomater Appl; 2021 Feb; 35(7):743-753. PubMed ID: 32807016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.